AOBiome's B244 demonstrated positive results from its Phase 2b trial for both Pruritus (Itch) and...
AOBiome Therapeutics, a clinical stage biotechnology company focused on transforming human health by developing topical biologic therapies for systemic inflammatory conditions, announced positive...
aobiome.com